Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05200364
Title A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Sutro Biopharma, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of South Florida, Tampa Florida 33612 United States Details
Thomas Jefferson University Philadelphia Pennsylvania 19017 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field